Catia Angiolini
About
In The Last Decade
Catia Angiolini
19 papers receiving 554 citations
Peers
Comparison fields: 5 of 67
- Oncology 280
- Hepatology 217
- Epidemiology 116
- Cancer Research 104
- Molecular Biology 84
Countries citing papers authored by Catia Angiolini
This map shows the geographic impact of Catia Angiolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catia Angiolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catia Angiolini more than expected).
Fields of papers citing papers by Catia Angiolini
This network shows the impact of papers produced by Catia Angiolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catia Angiolini. The network helps show where Catia Angiolini may publish in the future.
Co-authorship network of co-authors of Catia Angiolini
This figure shows the co-authorship network connecting the top 25 collaborators of Catia Angiolini. A scholar is included among the top collaborators of Catia Angiolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catia Angiolini. Catia Angiolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 10 | |
| 6 | 18 | |
| 7 | 10 | |
| 8 | 10 | |
| 9 | 27 | |
| 10 | 25 | |
| 11 | 18 | |
| 12 | Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients. | 2 |
| 13 | Capecitabine in association with epirubicin and docetaxel as first line chemotherapy in advanced breast cancer A dose-finding study | 8 |
| 14 | 13 | |
| 15 | 48 | |
| 16 | 61 | |
| 17 | 295 | |
| 18 | Reversal of autoimmune phenomena in autoimmune neutropenia after treatment with rhG-CSF: two additional cases. | 4 |
| 19 | [Promoting the improvement of clinical practice: guidelines]. | 1 |
| 20 | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.